Influence of oral intake of retinoids on the human plasma fibrinolytic system

Fibrinolysis and Proteolysis

Volumn 7, Issue 5, 1993, Pages 347-351

  Declerck, P J ^a   Boden, G ^a   Degreef, H ^a   Collen, D ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE; ETRETIN; ISOTRETINOIN; PLASMINOGEN ACTIVATOR INHIBITOR; RETINOID; TISSUE PLASMINOGEN ACTIVATOR;

ACNE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PSORIASIS;

EID: 0027494712     PISSN: 02689499     EISSN: None     Source Type: Journal    
DOI: 10.1016/0268-9499(93)90152-L     Document Type: Article

References (28)

1. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor
2. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis
3. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction
4. Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells
5. Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin and histamine
6. Thrombin regulation of mRNA levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells
7. Stimulation and desensitization of tissue plasminogen activator release from human endothelial cells
8. Cyclic AMP potentiates phorbol ester stimulation of tissue plasminogen activator release and inhibits secretion of plasminogen activator inhibitor-1 from human endothelial cells
9. Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells
10. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor
11. Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1
12. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor
13. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo
14. Regulation of plasminogen activator inhibitor-1 mRNA in human endothelial cells
15. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation
16. The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells
17. Regulation of type I plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha
18. The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression
19. Butyrate stimulates tissue-type plasminogen-activator synthesis in cultured human endothelial cells
20. Mechanism of induction of tissue-type plasminogen activator mRNA synthesis by retinoic acid in human endothelial cells
21. Stimulation of tissue-type plasminogen activator synthesis by retinoids in cultured human endothelial cells and rat tissues in vivo
22. Effect of retinoic acid on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in human endothelial cells
23. Stimulation by retinoids of tissue-type plasminogen activator secretion in cultured human endothelial cells: structure/ effect relationships
24. Induction of t-PA synthesis with intravenous bolus injection of vitamin A palmitate in vitamin A deficient rats
25. Fibrin plate method for estimating fibrinolytic activity
26. Assay of human tissuetype plasminogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA
27. An immunofunctional assay for active plasminogen activator inhibitor-1 (PAI-1)
28. Acute effects of retinoids on fibrinolysis before and after venous occlusion in healthy humans